IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAH1. A total of 25 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAMDEN ASSET MANAGEMENT L P /CA | 37,725,000 | $44,872,000 | 1.86% |
| SHENKMAN CAPITAL MANAGEMENT INC | 4,839,000 | $5,831,000 | 0.53% |
| AQR Arbitrage LLC | 13,500,000 | $16,193,000 | 0.46% |
| Context Capital Management, LLC | 3,934 | $4,719,000 | 0.44% |
| Polar Asset Management Partners Inc. | 7,000,000 | $8,387,000 | 0.09% |
| Calamos Advisors LLC | 9,500,000 | $11,397,000 | 0.05% |
| LINDEN ADVISORS LP | 6,998,000 | $8,394,000 | 0.04% |
| LAZARD ASSET MANAGEMENT LLC | 16,318,000 | $19,572,000 | 0.02% |
| Citadel Advisors | 68,788,000 | $82,290,000 | 0.02% |
| PUTNAM INVESTMENTS LLC | 7,564,000 | $8,997,000 | 0.01% |